Guangdong Jiaying Pharmaceutical Co Ltd (002198) - Total Assets

Latest as of March 2026: CN¥892.78 Million CNY ≈ $130.64 Million USD

Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) holds total assets worth CN¥892.78 Million CNY (≈ $130.64 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Guangdong Jiaying Pharmaceutical Co Ltd - Total Assets Trend (2004–2025)

This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see market cap of Guangdong Jiaying Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.

Guangdong Jiaying Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Guangdong Jiaying Pharmaceutical Co Ltd's total assets of CN¥892.78 Million consist of 59.2% current assets and 40.8% non-current assets. Review 002198 current and long-term liabilities to assess the company's total debt and financial obligations.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 19.4%
Accounts Receivable CN¥136.72 Million 16.1%
Inventory CN¥74.04 Million 8.7%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥76.11 Million 9.0%
Goodwill CN¥0.00 0.0%

Asset Composition Trend (2004–2025)

This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Guangdong Jiaying Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Guangdong Jiaying Pharmaceutical Co Ltd's current assets represent 59.2% of total assets in 2025, an increase from 25.1% in 2004.
  • Cash Position: Cash and equivalents constituted 19.4% of total assets in 2025, up from 3.3% in 2004.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, unchanged from 8.0% in 2004.
  • Asset Diversification: The largest asset category is accounts receivable at 16.1% of total assets.

Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Guangdong Jiaying Pharmaceutical Co Ltd based on total assets are shown below.

Company Country Total Assets
Pfizer Inc
NYSE:PFE
USA $201.13 Billion
AbbVie Inc
NYSE:ABBV
USA $136.46 Billion
Merck & Company Inc
NYSE:MRK
USA $129.80 Billion
AstraZeneca PLC
MX:AZNN
Mexico MX$114.07 Billion
Novartis AG ADR
NYSE:NVS
USA $122.03 Billion
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357
China CN¥2.89 Billion
Firebrick Pharma Ltd
AU:FRE
Australia AU$2.28 Million
Eli Lilly and Company
SA:LILY34
Brazil R$116.58 Billion

Guangdong Jiaying Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 4.25 9.90 5.12
Quick Ratio 3.80 8.51 4.19
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥414.15 Million CN¥475.86 Million CN¥367.49 Million

Guangdong Jiaying Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Guangdong Jiaying Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.36
Latest Market Cap to Assets Ratio 0.32
Asset Growth Rate (YoY) 1.2%
Total Assets CN¥849.23 Million
Market Capitalization $271.81 Million USD

Valuation Analysis

Below Book Valuation: The market values Guangdong Jiaying Pharmaceutical Co Ltd's assets below their book value (0.32x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Guangdong Jiaying Pharmaceutical Co Ltd's assets grew by 1.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)

The table below shows the annual total assets of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025.

Year Total Assets Change
2025-12-31 CN¥849.23 Million
≈ $124.27 Million
+1.24%
2024-12-31 CN¥838.82 Million
≈ $122.75 Million
-1.03%
2023-12-31 CN¥847.56 Million
≈ $124.03 Million
+0.11%
2022-12-31 CN¥846.65 Million
≈ $123.89 Million
+4.87%
2021-12-31 CN¥807.34 Million
≈ $118.14 Million
-0.14%
2020-12-31 CN¥808.44 Million
≈ $118.30 Million
-5.55%
2019-12-31 CN¥855.94 Million
≈ $125.25 Million
-3.78%
2018-12-31 CN¥889.56 Million
≈ $130.17 Million
+1.48%
2017-12-31 CN¥876.61 Million
≈ $128.28 Million
-20.25%
2016-12-31 CN¥1.10 Billion
≈ $160.86 Million
+4.89%
2015-12-31 CN¥1.05 Billion
≈ $153.35 Million
+1.23%
2014-12-31 CN¥1.04 Billion
≈ $151.49 Million
+12.65%
2013-12-31 CN¥919.00 Million
≈ $134.48 Million
+192.45%
2012-12-31 CN¥314.25 Million
≈ $45.98 Million
+2.51%
2011-12-31 CN¥306.55 Million
≈ $44.86 Million
+1.89%
2010-12-31 CN¥300.87 Million
≈ $44.03 Million
+18.77%
2009-12-31 CN¥253.33 Million
≈ $37.07 Million
+7.69%
2008-12-31 CN¥235.24 Million
≈ $34.42 Million
-4.17%
2007-12-31 CN¥245.48 Million
≈ $35.92 Million
+104.48%
2006-12-31 CN¥120.05 Million
≈ $17.57 Million
+31.59%
2005-12-31 CN¥91.23 Million
≈ $13.35 Million
+26.85%
2004-12-31 CN¥71.92 Million
≈ $10.52 Million
--

About Guangdong Jiaying Pharmaceutical Co Ltd

SHE:002198 China Drug Manufacturers - General
Market Cap
$271.81 Million
CN¥1.86 Billion CNY
Market Cap Rank
#15387 Global
#4540 in China
Share Price
CN¥3.66
Change (1 day)
-1.08%
52-Week Range
CN¥2.96 - CN¥8.43
All Time High
CN¥14.97
About

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat ailments, colds, orthopedics, rheumatism, gynecology, hepatobiliary diseases, tonics, and gastrointestinal disorders. It also provides Shuangliao Houfeng powder, Chongganling table… Read more